Ching Chen Chiu
Corporate Officer/Principal at BELITE BIO, INC
Profile
Ching Chen Chiu is currently the Vice President of Clinical Operations at Belite Bio, Inc. Prior to this, Chiu worked as an Executive Director at EPS International Co. Ltd.
and as a Managing Director and Director at CMIC Asia-Pacific Pte Ltd.
Chiu received a graduate degree from the University of Warwick and an undergraduate degree from Taipei Medical University.
Ching Chen Chiu active positions
| Companies | Position | Start |
|---|---|---|
| BELITE BIO, INC | Corporate Officer/Principal | 2021-10-31 |
Former positions of Ching Chen Chiu
| Companies | Position | End |
|---|---|---|
| CMIC Asia-Pacific Pte Ltd. | Chief Executive Officer | - |
EPS International Co. Ltd.
 EPS International Co. Ltd. Miscellaneous Commercial ServicesCommercial Services EPS International Co. Ltd. a subsidiary of a public listed company EPS Co. Ltd in Tokyo, Japan, commences its business operations in April 2007. The company aims to provide a seamless clinical research and development platform through strategizing and synergizing its established research networks, valuable knowledge, know-how, resources and experiences in Asia region. The company manages large- and small-scale, global and local clinical trials covering from first-in-man to post marketing surveillance for new chemical entities, biologics and medical devices. | Director/Board Member | - |
Training of Ching Chen Chiu
| Taipei Medical University | Undergraduate Degree |
| University of Warwick | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| BELITE BIO, INC | Health Technology |
| Private companies | 2 |
|---|---|
EPS International Co. Ltd.
EPS International Co. Ltd. Miscellaneous Commercial ServicesCommercial Services EPS International Co. Ltd. a subsidiary of a public listed company EPS Co. Ltd in Tokyo, Japan, commences its business operations in April 2007. The company aims to provide a seamless clinical research and development platform through strategizing and synergizing its established research networks, valuable knowledge, know-how, resources and experiences in Asia region. The company manages large- and small-scale, global and local clinical trials covering from first-in-man to post marketing surveillance for new chemical entities, biologics and medical devices. | Commercial Services |
| CMIC Asia-Pacific Pte Ltd. |
- Stock Market
- Insiders
- Ching Chen Chiu